FIELD: medicine.
SUBSTANCE: invention refers to air, fluid and surface cleansing and disinfection, and may be used in household use, medicine and industries. A method for air, fluid and surface cleansing consists in the decontamination of viruses from the same with a microporous silicon solution.
EFFECT: invention provides the effective air, fluid and surface decontamination of viruses with the low concentration of the working solution.
4 dwg, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| CATIONIC BRANCHED PEPTIDE FOR RESPIRATORY VIRUS INHIBITION | 2022 |
|
RU2810986C2 |
| METHOD FOR PRODUCTION OF SILICON NANOPARTICLES FOR CORONAVIRUS INFECTION INACTIVATION | 2022 |
|
RU2795525C1 |
| METHOD FOR PREVENTING AND TREATING BRONCHIAL ASTHMA, COMPLICATING RESPIRATORY VIRAL INFECTIONS AND OTHER RESPIRATORY INFLAMMATORY DISEASES | 2012 |
|
RU2526146C2 |
| COMBINED DRUG WITH ANTIVIRAL EFFECT AGAINST NEW SARS-COV-2 CORONAVIRUS | 2021 |
|
RU2746362C1 |
| APPLICATION OF COMPOSITION CONSISTING OF CATIONIC LTP PEPTIDE AND MOLECULES OF RNA AGAINST RESPIRATORY VIRUSES | 2015 |
|
RU2609857C1 |
| METHOD FOR ULTRASOUND AMPLIFICATION IN HYPERTHERMIA THERAPY OF TUMOUR TISSUES WITH USING SILICONE NANOCLUSTERS | 2010 |
|
RU2447915C1 |
| ANTIVIRAL ACTIVITY OF FULLERENE AQUEOUS SOLUTION | 2018 |
|
RU2694754C1 |
| AGENT FOR INHIBITION OF REPLICATION OF SARS-COV-2 VIRUS MEDIATED BY RNA INTERFERENCE | 2020 |
|
RU2733361C1 |
| COMPOSITION FOR VIRAL HEPATITIS C THERAPY | 2016 |
|
RU2639388C1 |
| PHARMACEUTICAL ANTI-HERPETIC COMPOSITION | 2004 |
|
RU2291690C2 |
